<HashMap><database>biostudies-other</database><scores/><additional><omics_type>Unknown</omics_type><volume>11(5)</volume><submitter>Liu N</submitter><journal>Marine drugs</journal><pagination>1524-33</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC3707159</full_dataset_link><abstract>Two new oxazole/thiazole derivatives, named tetroazolemycins A (1) and B (2), have been isolated from the acetone extract of the mycelium of Streptomyces olivaceus FXJ8.012 derived from deep-sea water, together with three known compounds, spoxazomicins A-C (3-5), isolated from the fermentation supernatant. The planar structure and relative configuration of tetroazolemycins were elucidated by a combination of spectroscopic analyses, including 1D- and 2D-NMR techniques, and showed to be new pyochelin-type antibiotics. Both compounds showed metal ion-binding activity and their Zn²? complexes exhibited weak activity against pathogenic bacteria Klebsiella pneumoniae.</abstract><repository>biostudies-other</repository><pmcid>PMC3707159</pmcid><data_source>Europe PMC</data_source><pubmed_authors>Xi L</pubmed_authors><pubmed_authors>Huang Y</pubmed_authors><pubmed_authors>Liu N</pubmed_authors><pubmed_authors>Shang F</pubmed_authors></additional><is_claimable>false</is_claimable><name>Tetroazolemycins A and B, two new oxazole-thiazole siderophores from deep-sea Streptomyces olivaceus FXJ8.012.</name><description>Two new oxazole/thiazole derivatives, named tetroazolemycins A (1) and B (2), have been isolated from the acetone extract of the mycelium of Streptomyces olivaceus FXJ8.012 derived from deep-sea water, together with three known compounds, spoxazomicins A-C (3-5), isolated from the fermentation supernatant. The planar structure and relative configuration of tetroazolemycins were elucidated by a combination of spectroscopic analyses, including 1D- and 2D-NMR techniques, and showed to be new pyochelin-type antibiotics. Both compounds showed metal ion-binding activity and their Zn²? complexes exhibited weak activity against pathogenic bacteria Klebsiella pneumoniae.</description><dates><release>2013-01-01T00:00:00Z</release><publication>2013 May</publication><modification>2019-03-27T01:12:46Z</modification><creation>2019-03-27T01:12:46Z</creation></dates><accession>S-EPMC3707159</accession><cross_references><pubmed>23665958</pubmed><doi>10.3390/md11051524 </doi></cross_references></HashMap>